Secor Alicia
Insider CIK 1584516 · GWPH Director · ZFGN Chief Commercial Officer · ZVRA Director · GTHX Director · ORTX Director · JNP President and CEO, Director · GEVA SVP, Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZVRA ZEVRA THERAPEUTICS, INC. | A Award deriv | 2026-06-04 | 2026-06-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | A Award deriv | 2025-12-02 | 2025-12-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer deriv | 2024-09-18 | 2024-09-18 | 30,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | D To issuer | 2024-09-18 | 2024-09-18 | 20,000 | — | $0 | 10,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | U Tender | 2024-09-18 | 2024-09-18 | 10,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2024-06-13 | 2024-06-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2024-06-13 | 2024-06-14 | 10,000 | — | $0 | 30,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 105,000 | — | $0 | 0 | SEC↗ |
| ORTX Orchard Therapeutics plc | D To issuer deriv | 2024-01-24 | 2024-01-24 | 46,000 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2023-06-15 | 2023-06-16 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2023-06-14 | 2023-06-16 | 105,000 | — | $0 | 105,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2022-06-23 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award | 2022-06-23 | 2022-06-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2022-06-07 | 2022-06-08 | 46,000 | — | $0 | 46,000 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 52,320 | — | $0 | 52,320 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2021-06-16 | 2021-06-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 35,340 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 22,464 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 34,416 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 3,144 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer deriv | 2021-05-05 | 2021-05-07 | 16,548 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | D To issuer | 2021-05-05 | 2021-05-07 | 10,584 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-03-01 | 2021-03-02 | 3,144 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-03-01 | 2021-03-02 | 1,260 | $17.85 | $22.5K | 10,584 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-03-01 | 2021-03-02 | 3,144 | — | $0 | 11,844 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2021-02-22 | 2021-02-25 | 22,464 | — | $0 | 22,464 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2021-01-04 | 2021-01-06 | 3,576 | — | $0 | 4 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | F Tax w/h | 2021-01-04 | 2021-01-06 | 1,440 | $9.62 | $13.9K | 8,700 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2021-01-04 | 2021-01-06 | 3,576 | — | $0 | 10,140 | SEC↗ |
| ORTX Orchard Therapeutics plc | A Award deriv | 2020-06-17 | 2020-06-19 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2020-06-04 | 2020-06-08 | 34,416 | — | $0 | 34,416 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-03-02 | 2020-03-04 | 1,296 | $8.34 | $10.8K | 16,440 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2020-01-03 | 2020-01-07 | 1,536 | $8.53 | $13.1K | 17,736 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | S Sale | 2019-03-13 | 2019-04-12 | 900 | $14.20 | $12.8K | 19,272 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 3,144 | — | $0 | 3,144 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 3,144 | — | $0 | 3,144 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 3,144 | — | $0 | 3,144 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | A Award deriv | 2019-03-01 | 2019-03-05 | 16,548 | — | $0 | 16,548 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise deriv | 2019-01-03 | 2019-03-15 | 3,580 | — | $0 | 0 | SEC↗ |
| GWPH GW PHARMACEUTICALS PLC | M Exercise | 2019-01-03 | 2019-03-15 | 3,580 | — | $0 | 20,172 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | D To issuer deriv | 2018-08-14 | 2018-08-15 | 127,500 | — | $0 | 0 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | D To issuer deriv | 2018-08-14 | 2018-08-15 | 225,000 | — | $0 | 0 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | D To issuer deriv | 2018-08-14 | 2018-08-15 | 110,000 | — | $0 | 0 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | D To issuer | 2018-08-14 | 2018-08-15 | 103,855 | $11.50 | $1.19M | 0 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | F Tax w/h | 2018-03-03 | 2018-03-06 | 1,870 | $8.80 | $16.5K | 86,355 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award deriv | 2018-02-09 | 2018-02-13 | 110,000 | — | $0 | 110,000 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award | 2018-02-09 | 2018-02-13 | 50,500 | — | $0 | 88,225 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | F Tax w/h | 2018-02-07 | 2018-02-09 | 3,475 | $8.40 | $29.2K | 37,725 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award | 2018-02-07 | 2018-02-09 | 10,000 | — | $0 | 41,200 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award deriv | 2017-03-03 | 2017-03-07 | 127,500 | — | $0 | 127,500 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award | 2017-03-03 | 2017-03-07 | 26,200 | — | $0 | 31,200 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | P Buy | 2016-08-25 | 2016-08-29 | 5,000 | $5.75 | $28.8K | 5,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2016-03-31 | 2016-04-04 | 53,000 | — | $0 | 53,000 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2016-03-31 | 2016-04-04 | 26,500 | — | $0 | 26,500 | SEC↗ |
| ZFGN ZAFGEN, INC. | M Exercise deriv | 2015-09-17 | 2015-09-21 | 25,000 | — | $0 | 134,235 | SEC↗ |
| ZFGN ZAFGEN, INC. | M Exercise | 2015-09-17 | 2015-09-21 | 25,000 | $9.67 | $241.8K | 26,256 | SEC↗ |
| ZFGN ZAFGEN, INC. | S Sale | 2015-09-17 | 2015-09-21 | 25,000 | $41.05 | $1.03M | 1,256 | SEC↗ |
| ZFGN ZAFGEN, INC. | S Sale | 2015-09-17 | 2015-09-21 | 1,256 | $41.05 | $51.6K | 0 | SEC↗ |
| ZFGN ZAFGEN, INC. | A Award deriv | 2015-02-27 | 2015-03-03 | 60,000 | — | $0 | 219,235 | SEC↗ |
| ZFGN ZAFGEN, INC. | P Buy | 2014-06-19 | 2014-06-23 | 4,000 | $20.00 | $80.0K | 4,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-09-19 | 2013-09-23 | 50,000 | — | $0 | 50,000 | SEC↗ |